Chinese Firm Sinopharm Reports Promising Results for COVID-19 Vaccine Trials
The anti-Covid vaccine from the Chinese pharmaceutical group Sinopharm, chosen by Morocco, is about to be completed thanks to the results of clinical trials.
In a press release, the pharmaceutical group indicated on Wednesday, November 11 that the data obtained from the large-scale clinical trials were "better than expected".
According to Reuters, the 3rd phase of clinical trials has been launched for the two vaccine candidates by China National Biotec Group (CNBG), which is a Sinopharm unit. These trials have been conducted in the United Arab Emirates, Bahrain and Egypt on more than 50,000 volunteers from these countries.
Pending the completion of the trials, the group should provide more details on the data from the trials of one of the two group’s vaccines.
Related Articles
-
220 dirhams on construction sites, up to 400 in the fields: Morocco lacks workers
25 August 2026
-
This Israeli company equips defense giants and also has clients in Morocco
24 August 2026
-
After three days in Algeria, a sanctioned Russian ship passes near Morocco
24 August 2026
-
In Brussels, a Moroccan name and being over 50: the profile most disadvantaged in hiring
24 August 2026
-
Morocco Has a New Billionaire Forbes Has Yet to Spot
24 August 2026